GP1a
GP1a is a potent agonist of cannabinoid receptor 2 (CB2) . Gp1a is beneficial to skin wound healing. GP1a inhibits inflammation and fibrogenesis while promoting re-epithelialization[1].
Product Specifications
CAS Number
511532-96-0
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gp1a.html
Purity
99.66
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=NN(C2=C(C=C(Cl)C=C2)Cl)C3=C1CC4=CC(C)=CC=C34)NN5CCCCC5
Molecular Formula
C23H22Cl2N4O
Molecular Weight
441.35
References & Citations
[1] Zhao C, et al. An enzyme-responsive Gp1a-hydrogel for skin wound healing. J Biomater Appl. 2021;36 (4) :714-721.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YP-W37720-01 48 Tests
Rat medium chain acyl-coenzyme A dehydrogenase (MCAD) ELISA Kit
Sign In for Pricing
View Details YP-W37720-02 96 Tests
Rat medium chain acyl-coenzyme A dehydrogenase (MCAD) ELISA Kit
Sign In for Pricing
View Details 
MBS6206963-01 0.1 mL
IRAK3 (Interleukin-1 Receptor-Associated Kinase 3, ASRT5, FLJ13601, IRAK-M, IRAKM) (MaxLight 490)
Sign In for Pricing
View Details MBS6206963-02 5x 0.1 mL
IRAK3 (Interleukin-1 Receptor-Associated Kinase 3, ASRT5, FLJ13601, IRAK-M, IRAKM) (MaxLight 490)
Sign In for Pricing
View Details